Home
Overview
Research & Development
Investors
Press Releases
Employment
Contact
2010
Share Placement Completed
Share Placement
Genesis Research Suspends NZ Operations
SPP Documents
2009
Share Purchase Plan Oversubscribed
Letter to Shareholders
Genesis Research Establishes Solirna Biosciences
Share Purchase Plan Announcement
Letter to Shareholders 7 July 2009
Annual Meeting Presentation
Genesis Research Updates Funding Status
Funding Discussions
Genesis Confirms Focus on New Gene Silencing Technology with Significant Potential
Financial Statements and Statutory Information
2009 Full Year Results
Genesis Research Swaps Royalty Stream for Equity Stake
Letter to Shareholders
Genesis Research Announces Settlement Delay
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
2011
2012
2001
20.11.2001
GENESIS AND SR PHARMA TO DEVELOP THERAPY FOR ECZEMA
20.09.2001
TRIAL SHOWS AVAC™ SAFE AND WELL TOLERATED FOR ASTHMA
31.08.2001
GENESIS ANNOUNCES RESULT OF ARBITRATION WITH FLETCHER CHALLENGE FORESTS
15.08.2001
GENESIS ACQUIRES 100% OF BIOSTORE LTD AND FIRST COMMERCIAL LICENSING AGREEMENT
07.08.2001
HALF YEAR RESULTS ANNOUNCED: GENESIS REVENUES UP 65% AT HALF YEAR
23.05.2001
GENESIS UNLOCKS WRIGHTSON SECRETS IN FORAGE GRASSES
16.02.2001
GENESIS CONFIRMS PVAC™ PSORIASIS TRIAL RESULTS
15.02.2001
GENESIS, CORIXA AND MEDICIS ANNOUNCE US PHASE II TRIAL RESULTS FOR PVAC™
31.01.2001
GENESIS RESEARCH DERIVES SURPLUS FROM FOURFOLD REVENUE INCREASE
[Home]